1. Home
  2. BZUN vs SGMO Comparison

BZUN vs SGMO Comparison

Compare BZUN & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.86

Market Cap

168.9M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.46

Market Cap

142.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
SGMO
Founded
2007
1995
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.9M
142.5M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
BZUN
SGMO
Price
$2.86
$0.46
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$4.20
$4.71
AVG Volume (30 Days)
177.9K
8.1M
Earning Date
11-25-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,372,022,139.00
$32,875,000.00
Revenue This Year
$6.27
$28.47
Revenue Next Year
$3.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.08
N/A
52 Week Low
$2.12
$0.38
52 Week High
$4.88
$2.84

Technical Indicators

Market Signals
Indicator
BZUN
SGMO
Relative Strength Index (RSI) 36.97 44.10
Support Level $2.66 $0.38
Resistance Level $3.04 $0.56
Average True Range (ATR) 0.14 0.05
MACD -0.00 0.01
Stochastic Oscillator 28.36 44.63

Price Performance

Historical Comparison
BZUN
SGMO

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: